Corporate Innovation

NVIDIA has secured partnerships with Eli Lilly and Thermo Fisher Scientific for its BioNeMo AI platform, targeting drug discovery infrastructure.¹ Multiple biotech firms including Terray, Apheris, and TetraScience have simultaneously adopted the platform for foundation model development. The coordinated enterprise adoption signals a shift from experimental AI trials to production-scale deployment in pharmaceutical R&D.

Autonomous robotics startups are securing commercial deployments across logistics, manufacturing, and healthcare sectors. Warehouse automation systems now handle 98% of inventory items, while Chinese robotics firms expand into Saudi Arabia's Vision 2030 infrastructure projects. Nuro targets late 2026 for robotaxi production following multi-year autonomous testing.